BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao Y, Zhang B, Wu Y, Wang Q, Wang J, Shen F. The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract 2018;2018:5480961. [PMID: 29849592 DOI: 10.1155/2018/5480961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Holster S, Rode J, Bohr J, Kumawat AK, Veress G, Hultgren Hörnquist E, Brummer RJ, König J. Faecal microbiota transfer in patients with microscopic colitis - a pilot study in collagenous colitis. Scand J Gastroenterol 2020;55:1454-66. [PMID: 33142068 DOI: 10.1080/00365521.2020.1839544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Oliphant K, Cochrane K, Schroeter K, Daigneault MC, Yen S, Verdu EF, Allen-Vercoe E. Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro. mSystems 2020;5:e00404-19. [PMID: 31992630 DOI: 10.1128/mSystems.00404-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Wah-Suárez MI, Vázquez MAM, Bosques-Padilla FJ. Inflammatory bowel disease: The role of commensal microbiome in immune regulation. Gastroenterol Hepatol 2021:S0210-5705(21)00253-3. [PMID: 34543718 DOI: 10.1016/j.gastrohep.2021.08.008] [Reference Citation Analysis]
4 Gulati M, Singh SK, Corrie L, Kaur IP, Chandwani L. Delivery routes for faecal microbiota transplants: Available, anticipated and aspired. Pharmacological Research 2020;159:104954. [DOI: 10.1016/j.phrs.2020.104954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 DuPont HL, Jiang ZD, DuPont AW, Utay NS. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Dig Dis Sci 2020;65:741-56. [PMID: 32008133 DOI: 10.1007/s10620-020-06102-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Schierová D, Březina J, Mrázek J, Fliegerová KO, Kvasnová S, Bajer L, Drastich P. Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy. Cells 2020;9:E2283. [PMID: 33066233 DOI: 10.3390/cells9102283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Ilan Y. Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation? Clin Exp Gastroenterol 2019;12:209-17. [PMID: 31190948 DOI: 10.2147/CEG.S203823] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 7.3] [Reference Citation Analysis]
8 Chen HT, Huang HL, Xu HM, Luo QL, He J, Li YQ, Zhou YL, Nie YQ, Zhou YJ. Fecal microbiota transplantation ameliorates active ulcerative colitis. ExpTher Med. 2020;19:2650-2660. [PMID: 32256746 DOI: 10.3892/etm.2020.8512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
9 Cláudio Lima de Jesus L, Alvarenga Lima F, Dias Coelho-rocha N, Fernando da Silva T, Paz J, Azevedo V, Mancha-agresti P, Martins Drumond M. Recombinant Probiotics and Microbiota Modulation as a Good Therapy for Diseases Related to the GIT. In: Claudia Salanță L, editor. The Health Benefits of Foods - Current Knowledge and Further Development. IntechOpen; 2020. [DOI: 10.5772/intechopen.88325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Oliphant K, Parreira VR, Cochrane K, Allen-Vercoe E. Drivers of human gut microbial community assembly: coadaptation, determinism and stochasticity. ISME J 2019;13:3080-92. [PMID: 31477821 DOI: 10.1038/s41396-019-0498-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
11 Stalder T, Kapel N, Diaz S, Grenouillet F, Koch S, Limat S, Daval F, Vuitton L, Nerich V. A systematic review of economic evaluation in fecal microbiota transplantation. Infect Control Hosp Epidemiol 2020;41:458-66. [DOI: 10.1017/ice.2019.371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Annese V. An update on treatment of ulcerative colitis. Expert Opinion on Orphan Drugs 2019;7:295-304. [DOI: 10.1080/21678707.2019.1638249] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]